NCT00004464View on ClinicalTrials.gov

Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

February 29, 1996

Primary Completion Date

March 1, 2007

Study Completion Date

November 11, 2008

Conditions
Aplastic AnemiaParoxysmal Hemoglobinuria, Nocturnal
Interventions
DRUG

cyclophosphamide

DRUG

filgrastim

Trial Locations (1)

21231

Johns Hopkins Oncology Center, Baltimore

All Listed Sponsors
lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00004464 - Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria | Biotech Hunter | Biotech Hunter